Effect of high glucose levels in human platelet NTPDase and 5′-nucleotidase activities

Diabetes Research and Clinical Practice

Volumn 81, Issue 3, 2008, Pages 351-357

  Lunkes, Gilberto Inácio ^a   Lunkes, Daniéle Sausen ^a   Leal, Daniela ^b   Araújo, Maria do Carmo ^b   Corrêa, Maísa ^a   Becker, Lara ^a   Rosa, Cintia Saydelles da ^a   Morsch, Vera Maria ^a   Schetinger, Maria Rosa Chitolina ^a  

^a Laboratorio de Sintese   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

5 nucleotidase; Diabetes; Hyperglycemia; Hypertension; NTPDase; Platelets

Indexed keywords

5' NUCLEOTIDASE; ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CAPTOPRIL; CD39 ANTIGEN; FRUCTOSE; FUROSEMIDE; GLIBENCLAMIDE; GLUCOSE; MANNITOL; METFORMIN; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; NUCLEOTIDASE; PROPRANOLOL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC HYPERTENSION; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYDROLYSIS; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; THROMBOCYTE RICH PLASMA;

5'-NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADULT; AGED; ALBUMINURIA; ANTIGENS, CD; APYRASE; BLOOD GLUCOSE; BLOOD PLATELETS; C-REACTIVE PROTEIN; CHOLESTEROL; DIABETES COMPLICATIONS; DIABETES MELLITUS; GLUCOSE; HUMANS; HYPERTENSION; MIDDLE AGED; NUCLEOSIDE-TRIPHOSPHATASE;

EID: 48949106591     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.06.001     Document Type: Article

References (40)

1. Lasne D., Jude B., and Susen S. From normal to pathological hemostasis. Can. J. Anaesth. 53 (2006) S2-S11
2. Denis C.V., and Wagner D.D. Platelet adhesion receptors and their ligands in mouse models of thrombosis. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 728-739
3. Jackson S.P. The growing complexity of platelet aggregation. Blood 109 (2007) 5087-5095
4. Fuchs I., Frossard M., Riedmüller E., Laggner A.N., and Jilma B. Platelets function in patients with acute coronary syndrome (ACS) predicts recurrent ACS. J. Thromb. Haemost. 4 (2006) 2547-2552
5. Smith T., Dhunnoo G., Mohan I., and Charlton-Menys V. A pilot study showing an association between platelet hyperactivity and the severity of peripheral arterial disease. Platelets 18 (2007) 245-248
6. Kahner B.N., Shankar H., Murugappan S., Prasad G.L., and Kunapuli S.P. Nucleotide receptor signaling in platelets. J. Thromb. Haemost. 4 (2006) 2317-2326
7. Cury C., Toth-Zsamboki E., Vemylen J., and Hoylaerts M.F. The platelet ATP and ADP receptors. Curr. Pharm. Des. 12 (2006) 859-875
8. Heptinstall S., Johnson A., Glenn J.R., and White E. Adenine nucleotide metabolism in human blood-important roles for leukocytes and erythrocytes. J. Thromb. Haemost. 3 (2005) 2331-2339
9. Gachet C. Regulation of platelet functions by P2 receptors. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 277-300
10. Marcus A.J., and Safier L.B. Thromboregulation: multicelular modulation of platelet reactivity in homeostasis and thrombosis. FASEB J. 7 (1997) 516-522
11. Cattaneo M. ADP receptors: inhibitory strategies for antiplatelet therapy. Drug News Perspect. 19 (2006) 253-259
12. Anfossi G., Russo I., Massucco P., Mattiello L., Cavalot F., Balbo A., et al. Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregation effect. Thromb. Res. 105 (2002) 71-78
13. Pilla C., Emanuelli T., Frasetto S.S., Battastini A.M.O., Dias R.D., and Sarkis J.J.F. ATP diphosphoydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets 7 (1996) 225-230
14. Zimmermann H. Ectonucleotidases: some recent developments and a note on nomenclature. Drug Dev. Res. 52 (2001) 44-56
15. Kawashima Y., Nagasawa T., and Ninomya H. Contribution of ecto-5′-nucleotidase to the inhibition of platelet aggregation by human endothelial cells. Blood 96 (2000) 2157-2162
16. Marcus A.J., Borekman M.J., Drosopouls J.H., Olson K.E., Islan N., Pinsky D.J., et al. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin. Thromb. Hemost. 31 (2005) 234-246
17. Atkinson B., Dwyer K., Enjyoji K., and Robson S.C. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: potential as therapeutic targets. Blood Cells Mol. Dis. 36 (2006) 217-222
18. Marcus A.J., Broekman M.J., Drosopoulos J.H.F., Islam N., Pinsky D.J., Sesti C., et al. Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). J. Thromb. Haemost. 1 (2002) 2497-2509
19. Sévigny J., Sundberg C., Braun N., Guckelberger O., Csizmadia E., Qawi I., et al. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphisphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 99 (2002) 2801-2809
20. Leal C.A., Schetinger M.R., Leal D.B., Bauchspiess K., Schrekker C.M., Maldonado P.A., et al. NTPDase and 5′-nucleotidase activities in platelets of human pregnants with a normal or high risk for thrombosis. Mol. Cell. Biochem. 304 (2007) 325-330
21. Lunkes G.I., Lunkes D., Stefanello F., Morsch A., Morsch V.M., Mazzanti C.M., et al. Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb. Res. 109 (2003) 189-194
22. Duarte M.M.F., Loro V.L., Rocha J.B.T., Leal D.B.R., de Bem A.F., Dorneles A., et al. Enzymes that hydrolyze adenine nucleotide of patients with hypercholesterolemia and inflammatory processes. FEBS J. 274 (2007) 2707-2714
23. Véricel E., Januel C., Carreras M., Moulin P., and Lagarde M. Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status. Diabetes 53 (2004) 1046-1051
24. Vaidyula V.R., Boden G., and Rao A.K. Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects. Platelets 17 (2006) 577-585
25. Yngen M., Norhammar A., Hjemdahl P., and Wallen N.H. Effects of improved metabolic control on platelet reactivity in patients with type 2 diabetes mellitus following coronary angioplasty. Diab. Vasc. Dis. Res. 3 (2006) 52-56
26. Calzada C., Coulon L., Halimi D., Le Coquil E., Pruneta-Deloche V., Moulin P., et al. In vitro glycoxidized low-density lipotreins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated protein kinase. J. Clin. Endocrinol. Metab. 92 (2007) 1961-1964
27. Michno A., Bielarczyk H., Paweczyk T., Jankowska-Kulawy A., Klimaszewska J., and Szutowicz A. Alteration of adenine nucleotide metabolism and function of blood platelets in patients with diabetes. Diabetes 56 (2007) 462-467
28. Miron V.R., Bauernmann L., Morsch A.L.B., Zanin R.F., Corrêa M., Silva A.C., et al. Enhanced NTPDase and 5′-nucleotidase activities in diabetes mellitus and iron-overload model. Mol. Cell. Biochem. 298 (2007) 101-107
29. Lominadze D., Joshua I.G., and Schuschke D.A. In vivo platelet thrombus formation in microvessels of spontaneously hypertensive rats. Am. J. Hypertens. 10 (1997) 1140-1146
30. 2+-ATPase activity. Anal. Biochem. 157 (1986) 375-380
31. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 218-254
32. Koszalka P., Ozuyaman B., Huo Y., Zernecke A., Flogel U., Braun N., et al. Targeted disruption of cd73/ecto-5′-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ. Res. 95 (2004) 814-821
33. Spanevello R.M., Mazzanti C.M., Maldonado P.A., Zanin R., Morsch A., Hannel L., et al. Activities of enzymes that hydrolyze adenine nucleotides in platelets from rats experimentally demyelinated with ethidium bromide and treated with interferon-β. Life Sci. 80 (2007) 1109-1114
34. Lunkes G.I., Lunkes D.S., Morsch V.M., Mazzanti C.M., Morsch A.L., Miron V.R., et al. NTPDase and 5′-nucleotidase activities in rats with alloxan-induced diabetes. Diabetes Res. Clin. Pract. 65 (2004) 1-6
35. Grant P.J. Diabetes mellitus as a prothrombotic condition. J. Int. Med. 262 (2007) 157-172
36. Hermans M.P. Diabetes and the endothelium. Acta Clin. Belg. 62 (2007) 97-101
37. Yamagishi S., Matsui T., Ueda S., Nakamura K., and Imaizumi T. Advanced glycation end products (AGEs) and cardiovascular disease (CVD) in diabetes. Cardiovasc. Hematol. Agents Med. Chem. 5 (2007) 236-240
38. Sakamoto T., Ogawa H., Kawano H., Hirai N., Miyamoto S., Takazoe K., et al. Rapid change of platelet aggregability in acute hyperglycemia. Detection by a novel laser-light scattering method. Thromb Haemost. 83 (2000) 475-479
39. Sobol A.B., and Watala C. The role of platelets in diabetes-related vascular complications. Diabetes Res. Clin. Pract. 50 (2000) 1-16
40. Preston R.A., Coffey J.O., Materson B.J., Ledford M., and Alonso A.B. Elevated platelet P-selection expression and platelet activation in high risk patients with uncontrolled severe hypertension. Atherosclerosis 192 (2007) 148-154